MCA
BMY icon

Magnolia Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Magnolia Capital Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$261K Sell
4,300
-1,105
-20% -$64.4K 0.05% 254
2025
Q4 		$292K Buy
+5,405
New +$260K 0.06% 233
2025
Q3 		– Sell
-4,491
Closed -$208K – 235
2025
Q2 		$208K Buy
4,491
+514
+13% +$25.2K 0.05% 228
2025
Q1 		$243K Buy
3,977
+3
+0.1% +$175 0.07% 207
2024
Q4 		$225K Buy
+3,974
New +$222K 0.06% 215

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Magnolia Capital Advisors's BMY Position: Q1 2026 in Review

Magnolia Capital Advisors reduced its Bristol-Myers Squibb (BMY) stake by 20% in Q1 2026, selling an estimated $64.4K and leaving 4,300 shares worth $261K. The position accounts for 0.05% of the portfolio, ranked #254.

Magnolia Capital Advisors first reported a position in BMY in Q4 2024 and has held it in 5 quarters since. The position peaked at $292K in Q4 2025. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Magnolia Capital Advisors held 4,300 shares of Bristol-Myers Squibb worth $261K as of Q1 2026.
  • Magnolia Capital Advisors sold 1,105 Bristol-Myers Squibb shares in Q1 2026, an estimated $64.4K.
  • Bristol-Myers Squibb made up 0.05% of Magnolia Capital Advisors's portfolio in Q1 2026, its #254 holding.
  • Magnolia Capital Advisors first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 5 quarters since.
  • Magnolia Capital Advisors's Bristol-Myers Squibb position peaked at $292K in Q4 2025.
  • 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Magnolia Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.